Manifestaciones extraesofágicas de la enfermedad por reflujo gastroesofágico

1. Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG Clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2022;117:27–56.

2. Durazzo M, Lupi G, Cicerchia F, et al. Extra-esophageal presentation of gastroesophageal reflux disease: 2020 update. J Clin Med 2020;9.

3. Martinucci I, Albano E, Marchi S, et al. Extra-esophageal presentation of gastroesophageal reflux disease: new Understanding in a new era. Minerva Gastroenterol Dietol 2017;63:221–234.

4. Vaezi MF, Katzka D, Zerbib F. Extraesophageal symptoms and diseases attributed to GERD: where is the pendulum swinging now? Clin Gastroenterol Hepatol 2018;16:1018–1029.

5. Hom C, Vaezi MF. Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment. Drugs 2013;73:1281–1295.

6. Zhang Z, Bao YY, Zhou SH. Pump proton and laryngeal H(þ)/ K(þ) ATPases. Int J Gen Med 2020;13:1509–1514.

7. Qiu Z, Yu L, Xu S, et al. Cough reflex sensitivity and airway inflammation in patients with chronic cough due to non-acid gastro-oesophageal reflux. Respirology 2011;16:645–652.

8. Kahrilas PJ, Altman KW, Chang AB, et al. Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report. Chest 2016;150:1341–1360.

9. Smith JA, Decalmer S, Kelsall A, et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology 2010;139:754–762.

10. Rangan V, Borges LF, Lo WK, et al. Novel advanced impedance metrics on impedance-pH testing predict lung function decline in idiopathic pulmonary fibrosis. Am J Gastroenterol 2022; 117:405–412.

11. House SA, Fisher EL. Hoarseness in adults. Am Fam Physician 2017;96:720–728.

12. Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon consensus. Gut 2018;67:1351–1362.

13. Numans ME, Lau J, de Wit NJ, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004;140:518–527.

14. Dent J, Vakil N, Jones R, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut 2010;59:714–721.

15. Kleiman DA, Beninato T, Bosworth BP, et al. Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease. J Gastrointest Surg 2014;18:26–33; discussion 34.

16. Carroll TL, Werner A, Nahikian K, et al. Rethinking the laryngopharyngeal reflux treatment algorithm: evaluating an alternate empiric dosing regimen and considering up-front, pH-impedance, and manometry testing to minimize cost in treating suspect laryngopharyngeal reflux disease. Laryngoscope

2017;127(Suppl 6):S1–S13. 17. Gyawali CP, Carlson DA, Chen JW, et al. ACG clinical guidelines: clinical use of esophageal physiologic testing. Am J Gastroenterol 2020;115:1412–1428.

18. Barrett CM, Patel D, Vaezi MF. Laryngopharyngeal reflux and atypical gastroesophageal reflux disease. Gastrointest Endosc Clin N Am 2020;30:361–376.

19. Cosway B, Wilson JA, O’Hara J. The acid test: proton pump inhibitors in persistent throat symptoms—a systematic review of systematic reviews. Clin Otolaryngol 2021;46:1263–1272.